showed a more modest association (empirical P = 0.039, PVE = 0.21). The AEI effect of the 5HTTLPR, after removing samples that are also heterozygotes for rs2020933, becomes more significant (average AEI = 0.75, n = 14, P = 0.000078). The total variance (of allelic ratio) explained by the two SNPs, which do not have independent effects, is about 50% and increases to 70% by adding the 5HTTLPR. There is only one individual (GM12717) with an extremely strong AEI (ratio = 2.4), which is homozygous for rs2020933, rs16965628 and the 5HTTLPR. This individual is the only heterozygote for a rare SNP, rs8073965, located 2.6 kb from rs2020933.
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We assessed our results in two neuronal cell lines, IMR-32 and SK-N-MC. We measured the allelic transcript level using SNP rs6354. The SK-N-MC cell line showed an imbalance in allelic expression, with a corrected C/A ratio of 1.42 (P = 4.65 Â 10
À10
). The ratio for IMR-32 was not significantly different from 1 (ratio = 1.09, P = 0.065).
To identify potential cis-acting variants, all coding sequences (15 exons) and promoter regions from the two cell lines were sequenced. IMR-32, which does not show AEI, is heterozygote for the 5HTTLPR but not for any other SNP. The SK-N-MC cell line is homozygote for the 5HTTLPR and for all other variants in the sequenced regions. We genotyped the cell lines for two of the SNPs that were identified to be potentially functional, rs2020933 and rs8073965. IMR-32 is homozygote for both SNPs, whereas SK-N-MC is heterozygote for rs2020933. This is consistent with the functional role of rs2020933 or other SNP in linkage disequilibrium and reinforced by the fact that the SNP is relatively rare in European populations (less than 10% are heterozygotes).
We asked whether two SNPs, rs2020933 and rs8073965, might individually, together or in combination with the 5HTTLPR contribute to variation in the anxiety and depression-related personality trait of neuroticism (N). SNP rs16965628 was not tested because of its high correlation with rs2020933, but we decided to test rs8073965 because, as noted above, the most extreme AEI was in the one individual (GM12717) that was heterozygote at this marker.
We genotyped 768 unrelated individuals from the extremes (10%) of the N-score distribution that were previously genotyped for the 5HTTLPR. 4 The allele distributions of rs2020933 and rs8073965 were not significantly different (P > 0.05) in the two extreme N groups as well as the haplotypes distribution of the two SNP and the 5HTTLPR.
Our results demonstrate how the effect of multiple genetic variants on gene expression can be efficiently investigated by assaying allelic imbalance in cell lines genotyped by the HapMap consortium. We have demonstrated that the 5HTTLPR and additional two SNPs contribute to variation in the expression of the serotonin transporter gene. These SNPs are in high correlation with each other, but not with the 5HTTLPR polymorphism, whose contribution to heritable expression variation is well studied. The serotonin transporter gene (SERT, SLC6A4) remains a candidate of high interest in obsessivecompulsive disorder (OCD) because patients with the disorder respond to central nervous system serotoninenhancing agents, such as selective serotoning reuptake inhibitors or clomipramine. Furthermore, SERT's most-studied functional polymorphism, 5-HTTLPR, has been associated with both the diagnosis of OCD in several studies 1,2 though not all; 3 and also with factor analysis-derived endophenotypic OCD subgroups. 4 An uncommon rare functional variant, I425V, which was originally found to segregate with OCD in two families, 5 was recently reported in an additional three OCD families. 6 In these five families, 10 diagnostically evaluated individuals with I425V all had OCD, and no one of the other eight family members without I425V had OCD (two individuals declined participation). SERT I425V is extremely rare in control populations. 5, 6 To extend the investigation of these two SERT variants, 5-HTTLPR and I425V, a selected cohort of individuals with psychiatric interview-assessed OCD were genotyped as described previously for 5-HTTLPR 1 and using a pyrosequencing method for I425V. 7 Clinical characteristics of this sample have been detailed previously. 8 The majority of the OCD sample was Caucasian (over 90%) whereas a similar proportion of the control sample was Caucasian.
As indicated in Table 1 , an association between SERT 5-HTTLPR and OCD diagnosis in the 149 new OCD patients compared to previously reported healthy volunteers 1 a trend for both the SS genotype (Pearson w 2 (1) = 5.521, P = 0.063) and the S allele frequency (Pearson w 2 (1) = 2.688, P = 0.101). I425V was not detected in any of the OCD probands. Positive I425V and negative assay controls were all correctly genotyped. The OCD sample included 23 individuals with multiple comorbid disorders (here defined as meeting criteria for three or more different axis I diagnoses in addition to OCD), a characteristic of the original I425V phenotype. 5 The OCD sample was collected under a protocol approved by the Johns Hopkins University Institutional Review Board.
The SS genotype is marginally associated with OCD in this report (0.05 < P < 0.10) and with anxiety traits in earlier reports. 9 In this report, allele proportions reflect comparable L:S allele rates in the population and in controls (L allele:S allele = 6:4), compared to OCD (L allele:S allele = 6:5). The S allele reduces SERT mRNA expression, whereas the L allele is a a gain-of-function variant, which may be mostly due to the L G allele. 10 Further studies are needed to clarify the relationship of these alleles to OCD, anxiety and neuroticism.
It is evident that larger samples beyond the total of OCD patients reported thus far in two prior reports and in this letter will be needed, as recommended by Delorme et al., 6 to adequately assess the relationship of I425V (and likewise 5-HTTLPR) to OCD -most likely through poled sample collections and genotyping via international collaborative groups such as the newly founded OCD Genetics Initiative (http:// www.ocfoundation.org). Additionally, transmission disequilibrium tests using family-based controls should be considered to control for population stratification. 
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